Barclays PLC Trims Stock Position in American Well Co. (NYSE:AMWL)

Barclays PLC cut its position in American Well Co. (NYSE:AMWL) by 95.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,108 shares of the company’s stock after selling 140,251 shares during the quarter. Barclays PLC’s holdings in American Well were worth $67,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of AMWL. Renaissance Technologies LLC raised its position in shares of American Well by 63.9% in the second quarter. Renaissance Technologies LLC now owns 6,833,500 shares of the company’s stock worth $2,220,000 after buying an additional 2,665,300 shares in the last quarter. Acadian Asset Management LLC raised its holdings in shares of American Well by 80.5% in the 2nd quarter. Acadian Asset Management LLC now owns 3,761,310 shares of the company’s stock valued at $1,220,000 after acquiring an additional 1,677,505 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of American Well by 28.1% during the 2nd quarter. AQR Capital Management LLC now owns 1,895,730 shares of the company’s stock valued at $616,000 after acquiring an additional 416,387 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of American Well by 2,690.2% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 419,841 shares of the company’s stock worth $136,000 after purchasing an additional 404,794 shares in the last quarter. Finally, Cubist Systematic Strategies LLC increased its position in shares of American Well by 7,673.8% in the second quarter. Cubist Systematic Strategies LLC now owns 184,083 shares of the company’s stock worth $60,000 after purchasing an additional 181,715 shares during the last quarter. 56.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

AMWL has been the subject of several research analyst reports. Morgan Stanley dropped their target price on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Needham & Company LLC restated a “hold” rating on shares of American Well in a research report on Thursday, October 31st.

American Well Price Performance

AMWL opened at $7.35 on Friday. American Well Co. has a 1 year low of $5.00 and a 1 year high of $29.00. The stock has a 50-day moving average price of $8.44 and a 200-day moving average price of $8.63. The firm has a market cap of $112.60 million, a PE ratio of -0.50 and a beta of 1.11.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.